K. O. Kliche

1.1k total citations
11 papers, 912 citations indexed

About

K. O. Kliche is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, K. O. Kliche has authored 11 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in K. O. Kliche's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cell death mechanisms and regulation (2 papers). K. O. Kliche is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cell death mechanisms and regulation (2 papers). K. O. Kliche collaborates with scholars based in United States and Germany. K. O. Kliche's co-authors include Michael Andreeff, Jan C. Liang, David F. Claxton, James Gajewski, Richard E. Champlin, Uday Popat, Aniruddha Choudhury, A. Wehmeier, M. Arning and David J. McConkey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

K. O. Kliche

11 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. O. Kliche United States 10 366 282 266 164 150 11 912
Mika Nishihara Japan 7 522 1.4× 246 0.9× 292 1.1× 83 0.5× 52 0.3× 9 996
Toshioki Sawaki Japan 17 84 0.2× 176 0.6× 241 0.9× 67 0.4× 138 0.9× 34 676
Hye‐Sook Kwon United States 12 395 1.1× 198 0.7× 423 1.6× 28 0.2× 148 1.0× 25 1.1k
Caroline Diveu France 11 1.1k 3.0× 386 1.4× 207 0.8× 153 0.9× 49 0.3× 11 1.4k
Amélie Montel‐Hagen United States 15 272 0.7× 283 1.0× 519 2.0× 52 0.3× 108 0.7× 25 1.0k
G. Delespesse Canada 14 518 1.4× 116 0.4× 222 0.8× 185 1.1× 63 0.4× 30 1.1k
Felix Clemens Richter United Kingdom 10 394 1.1× 183 0.6× 377 1.4× 36 0.2× 36 0.2× 24 979
Sailaja Narravula United States 6 215 0.6× 124 0.4× 823 3.1× 37 0.2× 495 3.3× 8 1.4k
María Ángeles García-López Spain 13 546 1.5× 233 0.8× 254 1.0× 65 0.4× 38 0.3× 20 1.0k
Parisa Amjadi United Kingdom 13 482 1.3× 146 0.5× 160 0.6× 32 0.2× 63 0.4× 15 762

Countries citing papers authored by K. O. Kliche

Since Specialization
Citations

This map shows the geographic impact of K. O. Kliche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. O. Kliche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. O. Kliche more than expected).

Fields of papers citing papers by K. O. Kliche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. O. Kliche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. O. Kliche. The network helps show where K. O. Kliche may publish in the future.

Co-authorship network of co-authors of K. O. Kliche

This figure shows the co-authorship network connecting the top 25 collaborators of K. O. Kliche. A scholar is included among the top collaborators of K. O. Kliche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. O. Kliche. K. O. Kliche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Sarris, A H, K. O. Kliche, A. Preti, et al.. (1999). Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Annals of Oncology. 10(4). 433–440. 132 indexed citations
3.
Konopleva, Marina, Adel A. Mikhail, Zeev Estrov, et al.. (1999). Expression and Function of Leptin Receptor Isoforms in Myeloid Leukemia and Myelodysplastic Syndromes: Proliferative and Anti-Apoptotic Activities. Blood. 93(5). 1668–1676. 146 indexed citations
4.
Clodi, Katharina, Shourong Zhao, K. O. Kliche, et al.. (1998). Coexpression of CD40 and CD40 ligand in B‐cell lymphoma cells. British Journal of Haematology. 103(1). 270–275. 52 indexed citations
5.
Chandra, Joya, K. O. Kliche, Michael Andreeff, et al.. (1998). Proteasome Inhibitors Induce Apoptosis in Glucocorticoid-Resistant Chronic Lymphocytic Leukemic Lymphocytes. Blood. 92(11). 4220–4229. 120 indexed citations
6.
Younes, Anas, Ugo Consoli, Virginia Snell, et al.. (1997). CD30 ligand in lymphoma patients with CD30+ tumors.. Journal of Clinical Oncology. 15(11). 3355–3362. 48 indexed citations
7.
Choudhury, Aniruddha, James Gajewski, Jan C. Liang, et al.. (1997). Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia. Blood. 89(4). 1133–1142. 238 indexed citations
8.
Chandra, Joya, Emil J. Freireich, K. O. Kliche, et al.. (1997). Protease Activation Is Required for Glucocorticoid-Induced Apoptosis in Chronic Lymphocytic Leukemic Lymphocytes. Blood. 90(9). 3673–3681. 51 indexed citations
9.
Younes, Anas, Saili Zhao, Virginia Snell, et al.. (1997). CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease. Annals of Oncology. 8. S97–S100. 9 indexed citations
10.
Arning, M., et al.. (1995). Infusion‐related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels. Mycoses. 38(11-12). 459–465. 86 indexed citations
11.
Novotny, G. E. K. & K. O. Kliche. (1986). Innervation of Lymph Nodes: A Combined Silver Impregnation and Electron-Microscopic Study. Cells Tissues Organs. 127(4). 243–248. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026